Cancer of Prostate: Clinical Trials

43 trials for Cancer of Prostate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 9 recruiting, 5 active not recruiting, 5 terminated. 15 Not applicable, 12 Phase 2, 7 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable15Completed 5, Recruiting 4, Active not recruiting 2, Terminated 2, Unknown 2
Phase 212Completed 5, Recruiting 3, Active not recruiting 2, Unknown 1, Withdrawn 1
Phase 17Terminated 3, Completed 2, Recruiting 1, Withdrawn 1
Phase 41Completed 1

Follow Cancer of Prostate: new trials by email Literature Review of Cancer of Prostate trials Research Report on Cancer of Prostate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Psilocybin therapy - Adjustment Disorder, Adjustment Disorder With Anxious Mood
Phase 2RecruitingPsyence Australia Pty Ltd872025-10-012026-10-29
Investigation of Three Biomarkers for the Detection of Prostate Cancer
Laboratory Biomarker Analysis: Enzyme-linked immunosorbent assay (ELISA) - Cancer of Prostate
CompletedMedtechtomarket Consulting Ltd1372025-01-072026-10-09
The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients
Dietary energy restriction, Daily exercise - Cancer of Prostate
Not applicableRecruitingMaastricht University Medical Center452024-10-122026-01-16
Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer
Dapagliflozin - Prostate Cancer, Cancer of Prostate
Phase 1TerminatedWashington University School of Medicine52024-06-042026-06-30
Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer
Stereotactic Ablative Body Radiation - Prostate Cancer, Cancer of Prostate
Not applicableRecruitingSunnybrook Health Sciences Centre1442024-03-012025-09-09
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
A web-based artificial intelligence (AI) auto-planning tool - Cancer of Prostate, Cancer Head Neck
Active not recruitingUniversity College, London10292023-12-072026-07-22
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
PDS01ADC, Stereotactic Body Radiation Therapy (SBRT) - Cancer Of Prostate
Phase 2RecruitingNational Cancer Institute (NCI)652023-06-122026-10-20
Real-time Motion Management During Prostate and Lung Radiotherapy
Triggered imaging on TrueBeam with margin reduction, Synchrony MLC tracking on fiducials with margin reduction, Synchrony MLC tracking and lung adaptive model with margin reduction - Cancer of Lung, Lung Metastasis
Not applicableActive not recruitingRegion Skane1322023-05-012026-07-28
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC
NUV-422, Enzalutamide - Prostate Cancer, Prostatic Cancer
Phase 1 / Phase 2WithdrawnNuvation Bio Inc.2022-09-012022-08-05
Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention
3D Robot-assisted laparoscopic radical prostatectomy and pelvic lymphadenectomy - Cancer of Prostate
Not applicableRecruitingFondazione del Piemonte per l'Oncologia1202022-06-292024-03-19
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
NUV-868, Olaparib, Enzalutamide - Advanced Solid Tumor, Ovarian Cancer
Phase 1TerminatedNuvation Bio Inc.822022-03-292025-11-06
Retzius-sparing Technique in Robotic-assisted Radical Prostatectomy
Retzius-repairing robot-assisted radical prostatectomy - Cancer of Prostate, Prostate Adenocarcinoma
Not applicableUnknownAnkara University802022-02-152022-02-04
A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors
Intervention, FitBit Only - Sedentary Behavior, Cancer of Prostate
Not applicableRecruitingUniversity of Toronto1202022-02-152024-12-04
Onco-primary Care Networking to Support TEAM-based Care
iGuide Intervention (Self-guided), iGuide 2 Intervention (Tailored/Targeted), Control - Blood Pressure, Hypertension
Not applicableActive not recruitingDuke University3132021-06-142026-02-20
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
Darolutamide, Radiotherapy - Advanced Prostate Carcinoma, Cancer of Prostate
Phase 2Active not recruitingTrans Tasman Radiation Oncology Group652021-06-022025-08-21
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
PDS01ADC, Docetaxel, M7824 - Cancer Of Prostate, Prostate Neoplasms
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)862021-02-232026-10-29
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
NUV-422 - Glioma, Glioma, Malignant
Phase 1TerminatedNuvation Bio Inc.742020-12-082023-07-14
Tailored, wEb-based, Psychosocial and Physical Activity Self-Management PrOgramme
TEMPO, Usual care - Cancer of Prostate, Anxiety
Not applicableCompletedSt. Mary's Research Center, Canada822020-06-012021-09-21
Hypertension Management in Cancer Patients
Automated Messaging - Blood Pressure, Hypertension
Not applicableTerminatedDuke University42019-12-102023-04-19
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP
Apalutamide, Leuprorelin Acetate 45Mg Powder for Injection Suspension Vial, Goserelin Acetate 10.8 MG Subcutaneous Implant - Cancer of Prostate
Phase 2UnknownCancer Research Antwerp2022019-04-052024-02-07

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

Prostatic Neoplasms (43)  ·  Neoplasms (7)  ·  Breast Neoplasms (6)  ·  Pancreatic Neoplasms (5)  ·  Colonic Neoplasms (3)  ·  Esophageal Neoplasms (3)  ·  Head and Neck Neoplasms (3)  ·  Kidney Neoplasms (3)  ·  Liver Neoplasms (3)  ·  Ovarian Neoplasms (3)  ·  Prostatic Neoplasms, Castration-Resistant (3)  ·  Stomach Neoplasms (3)  ·  Uterine Cervical Neoplasms (3)  ·  Anus Neoplasms (2)  ·  Carcinoma, Renal Cell (2)

Broader conditions

Genital Diseases (43)  ·  Genital Diseases, Male (43)  ·  Genital Neoplasms, Male (43)  ·  Male Urogenital Diseases (43)  ·  Neoplasms by Site (43)  ·  Prostatic Diseases (43)  ·  Urogenital Diseases (43)  ·  Urogenital Neoplasms (43)  ·  Neoplasms (36)  ·  Female Urogenital Diseases (7)  ·  Female Urogenital Diseases and Pregnancy Complications (7)  ·  Breast Diseases (6)  ·  Genital Diseases, Female (6)  ·  Genital Neoplasms, Female (6)  ·  Skin Diseases (6)

Interventions

Goserelin (2)  ·  Leuprolide (2)  ·  enzalutamide (2)  ·  2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (1)  ·  Androgen Antagonists (1)  ·  Blood Specimen Collection (1)  ·  Cognitive Behavioral Therapy (1)  ·  Docetaxel (1)  ·  Exercise (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Injections, Subcutaneous (1)  ·  Metformin (1)  ·  Methods (1)  ·  Multiparametric Magnetic Resonance Imaging (1)  ·  Observation (1)

Sponsors

National Cancer Institute (NCI) (7)  ·  Nuvation Bio Inc. (3)  ·  Duke University (2)  ·  Alliance Foundation Trials, LLC. (1)  ·  Ankara University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Astellas Pharma Inc (1)  ·  Cancer Research Antwerp (1)  ·  Danish Cancer Society (1)  ·  Dendreon (1)  ·  DxTerity Diagnostics (1)  ·  EDAP TMS S.A. (1)  ·  Exosome Diagnostics, Inc. (1)  ·  Fondazione del Piemonte per l'Oncologia (1)  ·  Fox Chase Cancer Center (1)

Countries

United States (23)  ·  France (5)  ·  Australia (3)  ·  Canada (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Netherlands (2)  ·  Austria (1)  ·  Denmark (1)  ·  Guadeloupe (1)  ·  India (1)  ·  Italy (1)  ·  Jordan (1)  ·  Malaysia (1)  ·  Martinique (1)

Top investigators

Melissa L Abel, M.D. (2)  ·  Andrew Stubbs, PhD (1)  ·  Arun Azad (1)  ·  Christoffer Johansen, PhD, Dr.Med (1)  ·  D. Buell, MD (1)  ·  Daniel Geynisman, MD (1)  ·  Danny Vesprini, MD (1)  ·  Deborah E Citrin, M.D. (1)  ·  Enrico Checcucci, MD (1)  ·  Eralp Kubilay (1)  ·  Franklin M Chu, MD (1)

Results publications

PMID 19171418, PMID 20566236, PMID 23856036, PMID 26345389, PMID 27553936, PMID 29595042, PMID 30237023, PMID 30293206, PMID 30486836, PMID 32356465, PMID 33568190, PMID 33743804, PMID 34711274, PMID 34794388, PMID 35079115, PMID 35084544, PMID 35484523, PMID 37129493, PMID 38594740, PMID 38713024, PMID 39168098, PMID 39996409, PMID 40462596

NIH funding

R37CA222885 (1), U01CA269143 (1)